{
    "code": 0,
    "data": [
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding additional disclosures to the Notice of Extra-Ordinary General Meeting dated January 07 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ec136e9-5e62-4606-bb22-d45ec6d40037.pdf",
            "news_date": "2026-02-04 15:23:37"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinizer Report and voting results of the Extra-Ordinary General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=655d6eae-bb05-4a10-af90-e2f892cdc39d.pdf",
            "news_date": "2026-01-31 16:20:17"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "EGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of EGM",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the proceedings of the Extra-Ordinary General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d7fc28e-77c1-46ed-bff5-c758d58b6031.pdf",
            "news_date": "2026-01-31 15:21:11"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Tuesday January 20 2026 for Q3FY26",
            "news_id": "2667edc3-0d77-455c-a440-ecf26e0ed220",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb349c3f-3a5a-4bfc-b22b-b952b3cda929.pdf",
            "news_date": "2026-01-27 18:15:35",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Tuesday January 20 2026 for Q3FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb349c3f-3a5a-4bfc-b22b-b952b3cda929.pdf",
            "news_date": "2026-01-27 18:15:35"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for extracts of Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0faa6bad-ac6d-40bc-8f71-7917834b7307.pdf",
            "news_date": "2026-01-21 11:27:09"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and nine months ended December 31 2025.",
            "news_id": "9fc19df5-f51a-4702-ab87-4584131167c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=149d8c3c-c868-4c2b-9756-b4a008c7bb71.pdf",
            "news_date": "2026-01-20 19:00:14",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=149d8c3c-c868-4c2b-9756-b4a008c7bb71.pdf",
            "news_date": "2026-01-20 19:00:14"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding statement of Deviation or Variation for quarter ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885ba82b-395d-409f-9a6e-568674642db6.pdf",
            "news_date": "2026-01-20 17:27:12"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Compliance",
            "descriptor": "Reg. 32 (1) (3) - Statement of Deviation & Variation",
            "caption": "Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding statement of Deviation or Variation for quarter ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=147a1380-2301-4794-a4a1-8d765794fb15.pdf",
            "news_date": "2026-01-20 17:26:47"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6b8d53f-a06a-4010-91c7-30bb473c2141.pdf",
            "news_date": "2026-01-20 15:30:54"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q3&9MFY26.",
            "news_id": "28c28f5c-411f-49cc-a5ac-b86e27715c89",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e0dcb04-9670-4851-a381-cf5c0a5d34fd.pdf",
            "news_date": "2026-01-20 15:23:44",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q3&9MFY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e0dcb04-9670-4851-a381-cf5c0a5d34fd.pdf",
            "news_date": "2026-01-20 15:23:44"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the Unaudited Standalone and Consolidated financial results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0277e9ec-6857-4fdf-9a57-addc505effac.pdf",
            "news_date": "2026-01-20 14:14:20"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Corrigendum To The Media Release Submitted With The Outcome Of The Board Meeting Dated January 20 2026",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Corrigendum to the Media Release submitted with the Outcome of the Board Meeting dated January 20 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bc87a8f-8ef0-425d-a424-cf850d5cde54.pdf",
            "news_date": "2026-01-20 14:07:20"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Nine Months Ended December 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the results for quarter and nine months ended December 31 2025",
            "news_id": "44df71ab-5e9d-49f2-aa5a-15d1efd58892",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4eaecfe-32ba-4b3a-97fd-91c220de08af.pdf",
            "news_date": "2026-01-20 13:37:35",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results For Quarter And Nine Months Ended December 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the results for quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a4eaecfe-32ba-4b3a-97fd-91c220de08af.pdf",
            "news_date": "2026-01-20 13:37:35"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 20 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b31a1d7-5ae8-42b5-9fc6-5192943ba85c.pdf",
            "news_date": "2026-01-20 13:29:06"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding updates on acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f88ca3d9-ab6a-4748-8d10-d4e60e0ade2b.pdf",
            "news_date": "2026-01-16 17:57:18"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q3FY26 scheduled to be held on January 20 2026 at 04:30 P.M. (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed84d4a4-fe0c-4d88-9904-0a3cee2c82ed.pdf",
            "news_date": "2026-01-15 14:44:20"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 And To Transact Other Business Matters",
            "news_body": "Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2026 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended December 31 2025 and to transact other business matters.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44077b11-16f2-4fa4-a8cf-7cbaf5bba32f.pdf",
            "news_date": "2026-01-13 18:54:38"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India ( Depositories and Participants)Regulations 2018 for quarter ended December 312025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10dc8ba7-4aed-4cbb-abb8-bc215aef68cc.pdf",
            "news_date": "2026-01-12 17:51:03"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication of Notice of Extra-Ordinary General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d3ae9cd-0aa5-47db-adbd-70e35d17db59.pdf",
            "news_date": "2026-01-12 11:06:26"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "EGM",
            "caption": "Notice Of Extra-Ordinary General Meeting Of The Company Scheduled To Be Held On Saturday January 31 2026",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Notice of the Extra-Ordinary General Meeting scheduled to be held on Saturday January 31 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7ff0c9d-7808-40b5-8426-8374f7c2fa20.pdf",
            "news_date": "2026-01-09 18:58:12"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 07 2026",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 07 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d855b321-25fa-4d2c-90ce-9726fd5d3f92.pdf",
            "news_date": "2026-01-07 18:11:45"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Evaluating Proposals For Raising Funds By Way Of Issue Of Convertible Warrants On Preferential Basis To The Promotors/Promoter Group Including Determination Of Issue Price",
            "news_body": "Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/01/2026 inter alia to consider and approve proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group including determination of issue price",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31323ac5-27ed-4e55-b8c7-5c9155912517.pdf",
            "news_date": "2026-01-03 20:55:22"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168699D2_2291_48F3_AEAB_0677754AB408_155304.pdf",
            "news_date": "2026-01-01 15:53:10"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Revised Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding revised intimation in respect of earlier intimation dated December 29 2025 under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ede54034-434d-452a-a9e2-010ddc82f962.pdf",
            "news_date": "2025-12-30 18:25:36"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a51da4e8-3f34-4a26-bb92-15c62aa62267.pdf",
            "news_date": "2025-12-29 18:46:16"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Transcript Of Business Update Call",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Business Update Call held on December 16 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0474097-3c4a-489f-a4d7-e2969ab0f650.pdf",
            "news_date": "2025-12-22 17:26:27"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding granting of Inter Corporate Loan",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e5c3491-10e6-4a1d-af50-f1343ac9241a.pdf",
            "news_date": "2025-12-20 14:49:47"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EF1FDB27_E77A_476E_B735_6FD925BA5711_122924.pdf",
            "news_date": "2025-12-18 12:29:28"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Audio Recording of Business Update Call",
            "news_id": "5210e64b-2c52-4274-af80-551580743247",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fccbd3c-3ef3-49ca-bca7-acd092f7d6dd.pdf",
            "news_date": "2025-12-16 16:44:06",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Audio Recording of Business Update Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fccbd3c-3ef3-49ca-bca7-acd092f7d6dd.pdf",
            "news_date": "2025-12-16 16:44:06"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Business update call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f96a29ae-1e33-4aee-9af8-c03891de1af1.pdf",
            "news_date": "2025-12-15 19:57:50"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Business update presentation",
            "news_id": "45e1976e-2971-48fb-945d-41d8794f2a74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a2c9f77-55fb-4efe-b3f1-530983767dc2.pdf",
            "news_date": "2025-12-15 19:54:28",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Business update presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a2c9f77-55fb-4efe-b3f1-530983767dc2.pdf",
            "news_date": "2025-12-15 19:54:28"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Acquisition",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2e0019a-5152-4754-bbc7-80bbc01b0d42.pdf",
            "news_date": "2025-12-15 19:47:26"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding Media Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a9bbe6f-66c4-438c-8f7f-5fea45fc6979.pdf",
            "news_date": "2025-12-11 21:30:39"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on December 11 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe8b6240-c6b6-48be-8e2d-d7271e1f0a0d.pdf",
            "news_date": "2025-12-05 18:08:04"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding press release dated December 05 2025 titled \"Senores Pharmaceuticals receives Philippine FDA approval for 10 products.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a94ba224-64b2-429b-bcaf-ed61fa82099d.pdf",
            "news_date": "2025-12-05 15:16:08"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 04 2025 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43C8402E_472D_4011_91AE_60A9147BB297_103440.pdf",
            "news_date": "2025-12-05 10:34:44"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
            "news_body": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on December 04 2025 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=518A2B65_2A1E_48F7_A5F4_605CB7FFB01F_103339.pdf",
            "news_date": "2025-12-05 10:33:42"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Thursday November 06 2025 for Q2 & H1FY26",
            "news_id": "29b2d096-2fed-4756-abf0-febacba850aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d6b5c6b-9d5b-417e-ac82-3aec59682705.pdf",
            "news_date": "2025-11-13 11:08:06",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Thursday November 06 2025 for Q2 & H1FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d6b5c6b-9d5b-417e-ac82-3aec59682705.pdf",
            "news_date": "2025-11-13 11:08:06"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper publication for Unaudited Standalone and Consolidated financial results for quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93d96428-5a99-4796-874e-327feead8990.pdf",
            "news_date": "2025-11-07 11:05:22"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange  regarding link of Audio recording of Earnings Conference Call for quarter and half year ended September 30 2025",
            "news_id": "d00d15aa-8c6c-448b-835f-f9feea2c55b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eb9728d-bb3a-4488-90c6-1ce5f0653697.pdf",
            "news_date": "2025-11-06 19:55:12",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange  regarding link of Audio recording of Earnings Conference Call for quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eb9728d-bb3a-4488-90c6-1ce5f0653697.pdf",
            "news_date": "2025-11-06 19:55:12"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca1f2cca-7944-4369-b895-2002a50e6425.pdf",
            "news_date": "2025-11-06 17:07:58"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding changes in the Senior Management Personnel (\"SMP\") of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d537801-e6e9-45a2-af7f-b465403e0b07.pdf",
            "news_date": "2025-11-06 15:04:48"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q2 & H1FY26",
            "news_id": "b0c98034-5cad-41d6-97eb-afe5ba85bf63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce4efec9-6bad-4249-90d2-721dcdb9caae.pdf",
            "news_date": "2025-11-06 14:18:37",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q2 & H1FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce4efec9-6bad-4249-90d2-721dcdb9caae.pdf",
            "news_date": "2025-11-06 14:18:37"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5285a884-8cd1-49a6-889c-64783feadcea.pdf",
            "news_date": "2025-11-06 14:11:37"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange the results for Quarter and half year ended September 302025",
            "news_id": "b249323d-29f3-4e0d-8cf4-517893d0ecdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54268f95-c854-4a67-a638-034be381c495.pdf",
            "news_date": "2025-11-06 14:04:38",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange the results for Quarter and half year ended September 302025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54268f95-c854-4a67-a638-034be381c495.pdf",
            "news_date": "2025-11-06 14:04:38"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On November 06 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of the Board Meeting held on November 062025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fc03496-38f8-4641-9c7f-8141901516fd.pdf",
            "news_date": "2025-11-06 14:00:26"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of  Securities and Exchange Board of India ( Listing Regulations and Disclosure Requirements) Regulations2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2acba217-28a1-4a0f-9887-1b77f7a08b7f.pdf",
            "news_date": "2025-11-05 18:46:11"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding updates on USFDA Inspection at Havix Group Inc. d/b/a Aavis Pharmaceuticals material subsidiary of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09826168-484b-430d-9dde-9d64363f30dd.pdf",
            "news_date": "2025-11-05 18:39:35"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q2FY26 scheduled to be held on November 06 2025 at 05:00 P.M. (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5739da0a-51be-450e-98ee-15639bd83b1c.pdf",
            "news_date": "2025-10-29 18:18:07"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025 And To Transact Other Business Matters",
            "news_body": "Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 302025 and to transact other business matters",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b551a4c-6478-42d4-b349-81569e5ddeff.pdf",
            "news_date": "2025-10-29 18:12:35"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Change In Email Address Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (RTA) Of The Company",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding change in email address of MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40611404-c5a0-4040-b904-cd349b09786d.pdf",
            "news_date": "2025-10-08 19:13:49"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange about the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6df0282-1e46-407f-808a-b091efba3a3f.pdf",
            "news_date": "2025-10-08 11:04:42"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed2d4d7c-d54c-4663-93a1-1bb37716a15d.pdf",
            "news_date": "2025-09-26 16:55:55"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Scrutinizer Report and voting results of 08th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8eaa16c8-d07a-410b-8008-29dc4f189014.pdf",
            "news_date": "2025-09-18 19:57:38"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the proceedings of the 08th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9815ec12-cb9b-48a3-b357-8e538f38125d.pdf",
            "news_date": "2025-09-18 18:50:53"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30(6) Of SEBI (LODR) Regulations 2015.",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding investment through Right Issue in Senores Pharmaceuticals Inc. Wholly Owned Subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=591d9a01-a746-4954-83c6-c87b1de275ac.pdf",
            "news_date": "2025-09-18 15:55:44"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding updates in respect of earlier intimations dated March 11 2025 March 122025  April 22 2025 and June 232025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f53b9528-0b19-4915-b0ba-5a40598fbfaf.pdf",
            "news_date": "2025-09-12 17:36:23"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding corrigendum to the Annual Report of the Company for the financial year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c56d04ea-2d45-434c-9b98-08988ef78f66.pdf",
            "news_date": "2025-09-05 16:07:12"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Re-Scheduling Of The Analyst / Institutional Investor Meetings Under The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the re-scheduling of the Analyst/ Institutional Investor meetings on September 03 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e25c3f2-254c-4dc3-a32e-e4315cc5b662.pdf",
            "news_date": "2025-09-02 14:50:59"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashokkumar Vijaysinh Barot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A7554A6E_3C97_4C78_A956_FB67CE343971_183358.pdf",
            "news_date": "2025-09-01 18:34:02"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C6AE5B16_3912_4900_8C4A_9C13F7A2A31F_172611.pdf",
            "news_date": "2025-09-01 17:26:15"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding schedule of Analyst / Institutional Investor Meeting on September 02 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9a98fb5-1c36-43f2-8f0a-c1de85fee42f.pdf",
            "news_date": "2025-08-28 17:20:38"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding Newspaper publication of the Notice of the Eighth (8th) Annual General Meeting of the members of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c14c47d-edea-49dc-b574-275512829b2e.pdf",
            "news_date": "2025-08-28 12:03:59"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of Eighth (8Th) Annual General Meeting To Be Held On September 18 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding Notice of Eighth (8th) Annual General Meeting to be held on September 18 2025 at 11:30 AM (IST) through VC/OAVM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81b9b291-48ab-4a42-863c-522dca96838a.pdf",
            "news_date": "2025-08-26 18:31:27"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding submission of Annual Report for the Financial Year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e6620e4-47a1-40a8-b25c-e2ee8d2fac95.pdf",
            "news_date": "2025-08-26 18:19:05"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashokkumar Barot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A67184A9_3BEF_4622_9C9C_9E2D30BF76A7_132457.pdf",
            "news_date": "2025-08-25 13:25:01"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9150FC4F_4BF1_404A_9CD8_AA86AEEF79E7_130257.pdf",
            "news_date": "2025-08-25 13:03:04"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhananjay Barot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E655DE74_8482_4BE7_9F8C_6F0F37EF908C_125610.pdf",
            "news_date": "2025-08-25 12:56:15"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhananjay Barot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C372FD67_AF29_41C8_9345_2DF71FACEB97_125508.pdf",
            "news_date": "2025-08-25 12:55:13"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhananjay Barot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6AB098C0_2D19_4773_BF45_C54410626CF6_125406.pdf",
            "news_date": "2025-08-25 12:54:11"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Cancellation Of Analyst / Institutional Investor Meetings Under The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding cancellation of participation of the Companys officials in the Analyst/Institutional Investor Meet scheduled today August 19 2025 in Mumbai due to some exigencies.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=285b6782-a1a9-44c3-a990-beefacd5bbfa.pdf",
            "news_date": "2025-08-19 11:35:34"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding schedule of Analyst/Investor meeting on August 19 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51f8f21c-6fce-4519-a12b-5cb734c32b08.pdf",
            "news_date": "2025-08-13 14:36:23"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding Media Release - \"Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA Inc.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61d5e3c9-6579-447c-afcb-f1fcbc4b28e3.pdf",
            "news_date": "2025-08-12 19:50:51"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding schedule of Analyst/Investor meeting on August 12 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=080065f1-d67c-4ae1-a094-290e2622f196.pdf",
            "news_date": "2025-08-05 17:59:40"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding transcript of Earnings Conference Call held on Thursday July 24 2025 for Q1FY26.",
            "news_id": "8365c5fa-d683-47d4-af56-b969f969099e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ad0fa0-3887-47a6-a7ec-cd78979980ab.pdf",
            "news_date": "2025-07-30 16:37:08",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding transcript of Earnings Conference Call held on Thursday July 24 2025 for Q1FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ad0fa0-3887-47a6-a7ec-cd78979980ab.pdf",
            "news_date": "2025-07-30 16:37:08"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EC2C6AF6_6F83_4B93_AA41_87D70B906CA7_094515.pdf",
            "news_date": "2025-07-30 09:45:35"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding completion of USFDA Inspection at Havix Group Inc. D/B/A Aavis Pharmaceuticals Material Subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33d21cbb-f5c5-4668-9d55-fde71cc997ca.pdf",
            "news_date": "2025-07-28 15:50:32"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Link of Audio recording of Earnings Conference Call for quarter ended June 30 2025",
            "news_id": "0e5c857d-19f5-41c8-8ab6-791dfae1e3be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=715b10a1-8445-4ccc-ba7e-502a738afbad.pdf",
            "news_date": "2025-07-24 18:18:45",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Link of Audio recording of Earnings Conference Call for quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=715b10a1-8445-4ccc-ba7e-502a738afbad.pdf",
            "news_date": "2025-07-24 18:18:45"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b91536ca-2f7d-46ce-92b3-39d809f31523.pdf",
            "news_date": "2025-07-24 12:11:03"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q1FY26.",
            "news_id": "fdcd2936-2164-41b2-8587-fc38e95cba6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac708ea4-5002-47b3-9d76-4bc491661e1f.pdf",
            "news_date": "2025-07-23 20:15:03",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q1FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac708ea4-5002-47b3-9d76-4bc491661e1f.pdf",
            "news_date": "2025-07-23 20:15:03"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb43129c-f04f-4503-8524-832cb5927310.pdf",
            "news_date": "2025-07-23 19:22:07"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47816bb7-0001-4cc6-9659-b6ed5f2e45b2.pdf",
            "news_date": "2025-07-23 19:09:14"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding change in the Senior Management Personnel(SMP) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95930fc9-c34e-44ed-a419-b50b7c418c7a.pdf",
            "news_date": "2025-07-23 18:52:43"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended On June 30 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Un-audited Standalone and Consolidated Financial Results for quarter ended on June 30 2025.",
            "news_id": "82ea23c2-fc50-406b-9fc4-71a849253be6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c48bc9ab-ce84-42b4-be3c-978c934d0737.pdf",
            "news_date": "2025-07-23 18:49:13",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For Quarter Ended On June 30 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Un-audited Standalone and Consolidated Financial Results for quarter ended on June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c48bc9ab-ce84-42b4-be3c-978c934d0737.pdf",
            "news_date": "2025-07-23 18:49:13"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On July 23 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of the Board Meeting held on July 23 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a062f2f9-287d-4952-a1f4-096b1b287a53.pdf",
            "news_date": "2025-07-23 18:41:01"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Earnings Conference Call for Q1FY26 scheduled to be held on July 24 2025 at 03:30 P.M. (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e989d58-3558-43f3-93e9-2d115de7e4c0.pdf",
            "news_date": "2025-07-19 12:30:51"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter  Ended June 30 2025And To Transact Other Business Matters",
            "news_body": "Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 inter alia to consider and approve Un-audited Standalone and Consolidated financial results of the Company for the quarter ended June 30 2025 and to transact other business matters.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=276c7899-3856-4aad-8d72-f4942ae71ea8.pdf",
            "news_date": "2025-07-17 12:06:09"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Resubmission Of Intimation For Issuance Of The Corporate Guarantee Dated July 10 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding resubmission of intimation dated July 10 2025 for giving corporate guarantee for credit facilities availed by Havix Group Inc. D/B/A Aavis Pharmaceuticals material subsidiary of the Company from HDFC Bank Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5bc268-8d2f-4e44-ad99-ccb335341e85.pdf",
            "news_date": "2025-07-14 16:34:52"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding acquisition of 6730 equity shares of Havix Group Inc. D/B/A Aavis Pharmaceuticals subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=937029d3-26ad-4c1b-a775-53196bf75785.pdf",
            "news_date": "2025-07-10 17:08:07"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange about the Certificate under Regulation 74(5) of SEBI(Depositories and Participants)Regulations 2018 for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8a26d6f-f2df-4d06-bdef-6c3e8fcf6ba2.pdf",
            "news_date": "2025-07-10 12:23:55"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb55bc9a-9619-4892-9bb9-2d45b38d2c78.pdf",
            "news_date": "2025-06-25 15:20:50"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update In Respect Of Our Earlier Intimations Dated March 11 2025 March 12 2025 And April 22 2025  Pursuant To Regulation 30 Of The SEBI (LODR) Regulations 2015",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding updates in respect of earlier intimations dated March 11 2025 March 12 2025 and April 22 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69dfb728-dd08-4f9f-9d6c-7113547a8cbd.pdf",
            "news_date": "2025-06-23 11:58:05"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding schedule of Analyst/ Investor meeting to be held on June 24 2025 and June 25 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a3e9b35-231d-4409-aad3-c083d9945b9c.pdf",
            "news_date": "2025-06-18 16:07:23"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Internal Auditors For FY 2025-26",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding appointment of Internal Auditors for FY 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f492d67-77a9-4ee4-ac6e-52c08536aab6.pdf",
            "news_date": "2025-06-02 14:02:37"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On June 02 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on June 02 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b8d3ace-c013-4bdd-89c4-199b01b6015b.pdf",
            "news_date": "2025-06-02 13:59:48"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding Submission of Secretarial Compliance Report for the financial year ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=097c1ec2-75e2-4e3c-bf58-1b21c304ddfd.pdf",
            "news_date": "2025-05-28 18:32:18"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Renosen Pharmaceuticals Pvt Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25FC9E52_8437_4AC1_90EC_CDC52448BA16_150600.pdf",
            "news_date": "2025-05-28 15:06:04"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Transcript of Earnings Conference Call held on Friday May 16 2025 for Q4FY25",
            "news_id": "e22b0182-8231-4bdd-8d1f-c2b62618981a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3da94862-93c4-4ac7-9508-a7e51a4203b1.pdf",
            "news_date": "2025-05-22 19:27:45",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding the Transcript of Earnings Conference Call held on Friday May 16 2025 for Q4FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3da94862-93c4-4ac7-9508-a7e51a4203b1.pdf",
            "news_date": "2025-05-22 19:27:45"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Media Release-\"Senores Pharmaceuticals acquires ANDA for Enalapril Maleate Tablets 2.5mg 5mg 10mg and 20mg from Wockhardt\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69abef17-54e2-4e0b-9aba-2d463eec1f52.pdf",
            "news_date": "2025-05-20 15:40:00"
        },
        {
            "co_code": 93477,
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Media Release- \"Senores Pharmaceuticals acquires ANDA for Enalapril Maleate Tablets 2.5mg 5mg10mg and 20mg from Wockhardt\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a48acc6-f1cd-48f5-be35-11be4adb56b2.pdf",
            "news_date": "2025-05-20 15:31:58"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding about Link of Audio recording of Earnings Conference Call for quarter and financial year ended March 31 2025.",
            "news_id": "c9e981b0-b9d1-4405-8870-5e1ef0ab718e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43e6850e-86ab-4f1f-84f5-71d8306ef077.pdf",
            "news_date": "2025-05-16 19:01:07",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For Quarter And Financial Year Ended March 31 2025",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding submission of Audited Standalone and Consolidated financial results for quarter and financial year ended March 31 2025",
            "news_id": "7f5187ea-bb62-4198-8dfd-80a28d9ac422",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ce7feff-eec5-4252-8dad-385809367244.pdf",
            "news_date": "2025-05-16 18:44:07",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q4 and FY25",
            "news_id": "7d3744d0-e244-423f-9bde-85206175de07",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=673ded1e-4680-446d-8ae0-b9609a20598e.pdf",
            "news_date": "2025-05-16 15:44:22",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Senores Pharmaceuticals Limited has informed the Exchange regarding Investor Presentation for Q4 and FY25.",
            "news_id": "5f1782aa-fb01-4a2f-a966-123135b6bcb4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46eafcf0-b828-46cb-975a-3c3bf038e3d2.pdf",
            "news_date": "2025-05-16 14:25:17",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Senores Pharmaceuticals Limited has informed the exchange regarding transcript of Earnings Conference Call held on January 23 2025.",
            "news_id": "a5016de4-3788-479f-9bfd-8327391ba410",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cf3f9dc-057c-43d5-8211-433755b6b5e1.pdf",
            "news_date": "2025-01-30 11:55:50",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SENORES",
            "disp": "Senores Pharmaceuticals",
            "bse_code": 544319,
            "isin": "INE0RB801010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Nine Months Ended December 31 2024",
            "news_body": "Results for quarter and nine months ended December 31 2024.",
            "news_id": "3d37f95f-da25-4279-a12c-85f4e258f36b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=338ae28d-3377-47fc-987c-ec57a05678ae.pdf",
            "news_date": "2025-01-23 13:55:08",
            "seo": "senores-pharmaceuticals-ltd",
            "ltp": 817.7,
            "ch": -10.75,
            "pch": -1.2976039592009172,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 28888,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}